Login
Toggle navigation
Videos
Categories
Trending
Mr. CEO Unveils Embraer's New Turboprop with 250+ LOIs | Arjan Meijer - CEO of Embraer
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Arjan Meijer is Pres/CEO:Commercial Aviation at Embraer SA.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Geoff Wilson AO: Championing Shareholder Advocacy for Retail Investors
00:10:00
Investment Partners were formerly with predecessor firm SV Investment Partners|NICHOLAS SOMERS, Managing Partner,SV Investment Partners
00:10:00
There is plenty to do for Digia | Timo Levoranta, CEO, Digia OyjDIGIA:HEX
00:10:00
New Era Business Forum Issue 45 Cover Feature: CAPE EMS BERHAD's MS CHRISTINA TEE | Tee Kim Chin (Christina) - Managing Director/ Group Chief Executive Officer of Cape Ems Bhd
00:10:00
World-Class Biathletes Ingrid Landmark Tandrevold and Johannes Thingnes Bø to Inspire Youth Pursuing Dreams in the Exciting Industry | Amund Tøftum - CEO of AF Group
00:10:00
Invests in future of work and the future of play not present day|Paige Doherty,Founding Partner,Behind Genius Ventures
00:10:00
DR Congo: Key Investment Hub for Cobalt and Lithium with Local Empowerment Focus
00:10:00
Unlocking the Deep Sea: Developing the World's Largest Battery Metal Resource
00:00:00
Dr. David Sinclair, Professor in Genetics, Harvard Medical School
00:10:00
Exploring Glenn Gould's Musical Ethos and Leonard Cohen's 'Democracy|Joshua Cohen,Professor,University of California, Berkeley
00:10:00
Watch Mr. Sohel Sadat, Chairman of SHIN SHIN GROUP, discuss the significance and impact of the Bangladesh Denim Expo in promoting the denim industry.
00:10:00
Thoma Bravo's Orlando Bravo Shares Post-Pandemic Strategy and Investing Insights in Exclusive Interview|Orlando Bravo,Founder,Thoma Bravo